SPECT imaging of body dysmorphic disorder.

Abstract

[99mTc]Hexamethylpropylene amine oxime (HMPAO) single photon emission computed tomography (SPECT) brain scans were undertaken in six subjects with body dysmorphic disorder (BDD). The scans showed a broad range of discrepant findings that do not immediately support a view of BDD as resting on either an obsessive-compulsive or affective disorder spectrum. Nevertheless, involvement of parietal regions is consistent with the characteristic altered body perception of BDD. These preliminary data highlight the need for further systematic functional imaging studies of this condition.

• Authors: Paul Carey, Soraya Seedat, James Warwick, Ben van Heerden, Dan J Stein
• Journal: The Journal of neuropsychiatry and clinical neurosciences (J Neuropsychiatry Clin Neurosci) Vol. 16 Issue 3 Pg. 357-9 ( 2004) ISSN: 0895-0172 [Print] United States
• PMID: 15377744 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Oximes
• Technetium Tc 99m Exametazime

Topics

• Adult
• Brain (diagnostic imaging, pathology)
• Female
• Humans
• Male
• Middle Aged
• Oximes (metabolism)
• Somatoform Disorders (diagnostic imaging)
• Technetium Tc 99m Exametazime (metabolism)
• Tomography, Emission-Computed, Single-Photon (methods)
• Tomography, X-Ray Computed